Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Chart: Pfizer Revenue Boosted by Covid-19 Drugs | Statista
Pfizer Limited net cash 2024| Statista
Pfizer Share Price: What to Expect from Q4 Results - IG UK
Pfizer CEO defends turnaround strategy as activist pressures management ...
Why Pfizer Looks Better Than Moderna as a Long-Term Buy | citybiz
Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 billion ...
Pfizer Weighs Splitting Up New Drug Behemoth - WSJ
Pfizer cash dividends paid 2024| Statista
Tashkent, Uzbekistan - 22 November, 2021: Pile of us dollars and Pfizer ...
Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine - The ...
Strategy Study: The Pfizer Growth Study
Pfizer buys Medivation $14 billion cash
Pfizer Piles Profits Abroad - WSJ
Pfizer inks $5.4 billion deal for sickle cell disease treatment - The ...
Pfizer Throws Out Plan to Split Into Two Companies - WSJ
Pfizer lifts profit view on cost cuts, demand for COVID products | Reuters
Pfizer to buy Array Biopharma for $48 a share in cash
Moderna demanda a Pfizer por un presunto plagio de su vacuna contra la ...
Pfizer completes up to $10 billion acquisition of Metsera | Reuters
Pfizer lifts profit forecast as investors await turnaround | Reuters
Pfizer Spending Twice As Much On Selling Than Research?
Pfizer posts surprise 4th quarter profit, but key products miss on ...
| Pfizer
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other ...
Pfizer Is Rising Past Covid-19
Pfizer and AstraZeneca announce new investments of nearly $1 billion in ...
Exclusive: Pfizer to invest €1 billion in new Dublin biotech plant ...
Pfizer’s financial performance in 2022 | Pfizer 2022 Annual Report
Pfizer liabilities 2025| Statista
Pfizer Q2 Revenue Misses Expectations as COVID Product Demand Slumps
Pfizer enters weight loss drug market with Novo Nordisk, Eli Lilly
Pfizer (NYSE:PFE) Seems To Use Debt Rather Sparingly | Nasdaq
Pfizer Chief on Drug Pricing - The New York Times
Pfizer long-term debt 2008-2024| Statista
US companies prioritise liquidity over investment returns - EuroFinance ...
Tornado at Pfizer Warehouse Likely to Worsen Shortage of Surgical Drugs ...
Pfizer expects to hike U.S. COVID vaccine price to $110-$130 per dose ...
Pfizer lifts profit forecast as investors await turnaround
Pfizer is betting big on cancer drugs after Covid decline
Editorial Pfizer Logo On Glass Building Stock Motion Graphics SBV ...
Pfizer Q3 earnings 2018
Pfizer Does Not Need A Merger, It Needs A Rebellion
Pfizer ruling spotlights unresolved, basic issue in recent affirmative ...
Pfizer Share Price: What to Expect from Q1 Results | IG International
Pfizer pins hopes on record pipeline to recover from post-Covid ...
Pfizer To Buy Arena Pharmaceuticals in $6.7 Billion All-Cash Deal ...
Pfizer moved late-game campaign cash to Kotek, legislative leaders ...
Pfizer reveals promising data for its new anti-obesity drug | Crain's ...
Pfizer set for record vaccine revenue as world’s dose-sharing ...
Pfizer to pay $6.7B in cash for Arena Pharmaceuticals | AP News
Pfizer (PFE) Q1 Earnings Beat, COVID-19 Vaccine Boosts Sales
Could Pfizer Stock Help You Become a Millionaire? | The Motley Fool
Pfizer and Moderna investors brace for eventual drop in vaccine sales ...
Forget the Vaccine, Buy Pfizer Stock for Its Impressive Cash Flow
Pfizer Stock: Largest Big Pharma Insider Buy Since 2003
Why Pfizer sorely needs the activist treatment
Pfizer Kicks Off Big Pharma Earnings With a Beat. The Stock Is Rising ...
Is Pfizer Stock a Buy? | The Motley Fool
How much could Pfizer make from a COVID-19 vaccine? - Marketplace
(PDF) Pfizer Financial Performance Analysis Report 2019-2022
Throw Growth Aside and See Pfizer Stock as Top Dividend and Cash Flow ...
Pfizer Stock Surges as CEO Plans to Profit From Covid-19 Vaccine
What To Expect From Pfizer In The Post-COVID-19 Era (NYSE:PFE ...
Pfizer (PFE) Q1 Earnings Top, Biopharma Gains From Coronavirus
3 Reasons PFE is Risky and 1 Stock to Buy Instead - The Globe and Mail
The Biggest Cash Cows of the Largest Companies
How Does Pfizer’s Revenue And Other Key Metrics Compare With That of Merck?
Pfizer's COVID cash pile opens opportunities for deals | Reuters
Chart: A Covid Vaccine-Sized Hole in Pfizer's Revenue | Statista
Pfizer, BioNTech Seek FDA Authorization for Updated Covid-19 Vaccine - WSJ
Pfizer's Weight-Loss Drug Won't Enter a Phase 3 Trial. The Stock Drops ...
This recovering pharma giant is a once-in-a-generation bargain ...
Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales | Nasdaq
SNP Group | SNP’s Executive Board and Supervisory Board recommend ...
3 Reasons PFE is Risky and 1 Stock to Buy Instead — TradingView News
Pfizer's balance sheet is 'bulletproof' thanks to Covid vaccine, says ...
Could Covid vaccine be a catalyst for reversal of equity factors that ...
How to Invest in US Stocks From India: 2025 - A Practical Guide
107408338-1714497860158-gettyimages-1971289600-pfizerearningsreport03 ...
How Much Is Pfizer's Consumer Healthcare Business Worth?
107366244-1706618176217-gettyimages-1971421128-pfizer33.jpeg?v ...
FILE - In this Jan. 25, 2009 file photo, Pfizer's world headquarters is ...
Cash Flow Forecasting | Modano
Nestlé to Buy Pfizer's Infant-Nutrition Unit - WSJ
Medivation shares surge on Pfizer's $14 billion offer
Revolutionizing Healthcare: Pfizer’s AI Journey to Drug Discovery and ...
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?
Pfizer's Quarterly Earnings Preview: What You Need to Know
107341903-1701439925108-gettyimages-1235943880-PGONCHAR_W7182.jpeg?v ...
Pfizer: A Deep Value Play for the Long Term
Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow ...
Pfizer's Post-Pandemic Pivot (NYSE:PFE) | Seeking Alpha
Pfizer: Juicy Dividend, Strong Pipeline, Big Gains - Barron's
Why Pfizer's Q2 Update Was Even Better Than You Might Think | The ...
Here Are 31 Billion Reasons to Love Pfizer's Stock Right Now | The ...
Why Pfizer's Earnings Are Outstanding | The Motley Fool
Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024 ...
Pfizer: Is This Pharma Giant Finally A Bargain (NYSE:PFE) | Seeking Alpha
Pfizer: Pipeline Monetization Shows Great Promise - Rich Yields Pending ...
Pfizer's Problems Go Far Beyond Just Declining COVID Revenue | The ...
Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major ...
Pfizer: Significant Plunge Offering Exceptional Buying Opportunity ...
FDA approves etrasimod, Pfizer’s oral drug for ulcerative colitis
Pfizer's Q4 revenue slump tied to vaccine slowdown
:max_bytes(150000):strip_icc()/INV_Pfizer_GettyImages-1244086770-29e584475a4746d79773c099d4e20816.jpg)
:max_bytes(150000):strip_icc()/PFE_SPXTR_chartcopy-b69ab0fd7ce04aaa92ed468723d29541.jpg)
